期刊论文详细信息
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 卷:108
IFN-γ and IL-12 plasmid DNAs as vaccine adjuvant in a murine model of grass allergy
Article
Kumar, M ; Behera, AK ; Hu, JN ; Lockey, RF ; Mohapatra, SS
关键词: allergen;    adjuvant;    cytokines;    plasmids;    T(H)1;    T(H)2;    inflammation;    airway hyperresponsiveness;   
DOI  :  10.1067/mai.2001.117261
来源: Elsevier
PDF
【 摘 要 】

Background: Plasmids encoding cytokines such as IFN-gamma and IL-12 are potential genetic adjuvants that might increase the effectiveness of allergen vaccines. Objective: The role of plasmids expressing the cytokines IFN-gamma (pIFN-gamma) and/or IL-12 (pIL-12) as adjuvants in modulating allergic immune responses, inflammation, and asthma was investigated in a murine model of Kentucky blue grass (KBG) allergy. Methods: Groups of naive B6D2F1 mice were vaccinated subcutaneously with KBG allergens and administered intramuscularly with pIFN-gamma, pIL-12, pIFN-gamma plus pIL-12, or a vector control. Mice were then sensitized with KBG allergens in alum (intraperitoneally) and later challenged intranasally. Mice were examined for modulation or specific immunity, prevention of the development of airway hyperresponsiveness, and inflammation. Results: Mice vaccinated with cytokine plasmid adjuvants had relatively lower levels of total serum IgE and higher levels of grass allergen-specific IgG2a in comparison with control mice. The lowest IgE and highest IgG2a levels were found in mice vaccinated with the combination of pIFN-gamma and pIL-12 as an adjuvant. The vaccination of mice with both pIFN-gamma and pIL-12 as an adjuvant induced the highest level of T(H)1 cytokines, IFN-gamma, and IL-2 in comparison with mice given either of the plasmids alone. The most profound decrease in airway hyperresponsiveness and pulmonary inflammation was observed in mice receiving both pIFN-gamma and pIL-12 as an adjuvant. Conclusion: These results demonstrate that pIFN-gamma and pIL-12 together provide an effective adjuvant to parenteral grass allergen vaccines and show that this adjuvant can significantly enhance the effectiveness of allergen immunotherapy in human beings.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1067_mai_2001_117261.pdf 259KB PDF download
  文献评价指标  
  下载次数:0次 浏览次数:0次